Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison
Open Access
- 18 October 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 28 (1) , 60-67
Abstract
What is the treatment success rate of systemic methotrexate (MTX) compared with expectant management in women with an ectopic pregnancy or a pregnancy of unknown location (PUL) with low and plateauing serum hCG concentrations? In women with an ectopic pregnancy or a PUL and low and plateauing serum hCG concentrations, expectant management is an alternative to medical treatment with single-dose systemic MTX. MTX is often used in asymptomatic women with an ectopic pregnancy or a PUL with low and plateauing serum hCG concentrations. These pregnancies may be self-limiting and watchful waiting is suggested as an alternative, but evidence from RCTs is lacking. The results of this RCT show that expectant management is an alternative to treatment with systemic MTX in a single-dose regimen in these women. A multicentre RCT women were assigned to systemic MTX (single dose) treatment or expectant management, using a web-based randomization program, block randomization with stratification for hospital and serum hCG concentration (<1000 versus 1000–2000 IU/l). The primary outcome measure was an uneventful decline of serum hCG to an undetectable level (18 years old with both an ectopic pregnancy visible on transvaginal sonography and a plateauing serum hCG concentration <1500 IU/l or with a PUL and a plateauing serum hCG concentration <2000 IU/l were eligible for the trial. We included 73 women of whom 41 were allocated to single-dose MTX and 32 to expectant management. There was no difference in primary treatment success rate of single-dose MTX versus expectant management, 31/41 (76%) and 19/32 (59%), respectively [relative risk (RR) 1.3 95% confidence interval (CI) 0.9–1.8]. In nine women (22%), additional MTX injections were needed, compared with nine women (28%) in whom systemic MTX was administered after initial expectant management (RR 0.8; 95% CI 0.4–1.7). One woman (2%) from the MTX group underwent surgery compared with four women (13%) in the expectant management group (RR 0.2; 95% CI 0.02–1.7), all after experiencing abdominal pain within the first week of follow-up. In the MTX group, nine women reported side effects versus none in the expectant management group. No serious adverse events were reported. Single-dose systemic MTX does not have a larger treatment effect compared with expectant management in women with an ectopic pregnancy or a PUL and low and plateauing serum hCG concentrations. Sixty percent of women after expectant management had an uneventful clinical course with steadily declining serum hCG levels without any intervention, which means that MTX, a potentially harmful drug, can be withheld in these women. A limitation of this RCT is that it was an open (not placebo controlled) trial. Nevertheless, introduction of bias was probably limited by the strict criteria to be fulfilled for treatment with MTX. This trial is supported by a grant of the Netherlands Organization for Health Research and Development (ZonMw Clinical fellow grant 90700154). ISRCTN 48210491.Keywords
This publication has 16 references indexed in Scilit:
- Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcomeFertility and Sterility, 2011
- Introduction of a single visit protocol in the management of selected patients with pregnancy of unknown location: a prospective studyBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Ectopic PregnancyNew England Journal of Medicine, 2009
- ACOG Practice Bulletin No. 94: Medical Management of Ectopic PregnancyObstetrics & Gynecology, 2008
- Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trialFertility and Sterility, 2006
- General obstetrics: Failing pregnancies of unknown location: a prospective evaluation of the human chorionic gonadotrophin ratioBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- The non‐surgical management of ectopic pregnancyUltrasound in Obstetrics & Gynecology, 2005
- Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancyAmerican Journal of Obstetrics and Gynecology, 2005
- Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysisUltrasound in Obstetrics & Gynecology, 2004
- Predictors of Success of Methotrexate Treatment in Women with Tubal Ectopic PregnanciesNew England Journal of Medicine, 1999